Clinical Study
Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation
Table 1
Patient characteristics.
| | Characteristics | |
| | Age (years) | | | Male | 17 (63%) | | Body mass index (kg/m2) | | | Ethnicity | | | Caucasian | 16 (59%) | | Black | 8 (30%) | | Presumptive cause of ESRD | | | Hypertensive nephrosclerosis | 6 (22%) | | Chronic glomerulonephritis | 6 (22%) | | Diabetic nephropathy | 5 (19%) | | Other | 10 (37%) | | Comorbidities | | | Hypertension | 26 (97%) | | Dyslipidemia | 20 (74%) | | Diabetes | 7 (26%) | | Coronary artery disease | 9 (33%) | | Smoking | 5 (19%) | | Dialysis modality | | | In-center hemodialysis | 17 (63%) | | Home hemodialysis | 4 (15%) | | Peritoneal dialysis | 5 (19%) | | Predialysis | 1 (4%) | | Time spent on dialysis (years) | | | Prior kidney transplantation | 3 (11%) | | Prior subtotal parathyroidectomy | 2 (7%) | | Follow-up after transplant (years) | | | Cinacalcet use after transplant (months) | |
|
|
Continuous variables are expressed as mean ± standard deviation; categorical variables are expressed as count (%).
|
